Publication Information

{'id': 'https://openalex.org/W1830687917', 'doi': 'https://doi.org/10.1111/j.1365-2710.2012.01349.x', 'title': 'Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects', 'display_name': 'Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects', 'publication_year': 2012, 'publication_date': '2012-06-07', 'ids': {'openalex': 'https://openalex.org/W1830687917', 'doi': 'https://doi.org/10.1111/j.1365-2710.2012.01349.x', 'mag': '1830687917', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22676397'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2710.2012.01349.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S156693432', 'display_name': 'Journal of Clinical Pharmacy and Therapeutics', 'issn_l': '0269-4727', 'issn': ['0269-4727', '1365-2710'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://doi.org/10.1111/j.1365-2710.2012.01349.x', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5015685796', 'display_name': 'David L. Cutler', 'orcid': 'https://orcid.org/0000-0002-8164-1082'}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'D. L. Cutler', 'raw_affiliation_strings': ['Merck Sharp and Dohme Corp., Whitehouse Station, NJ'], 'affiliations': [{'raw_affiliation_string': 'Merck Sharp and Dohme Corp., Whitehouse Station, NJ', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045456371', 'display_name': 'Amol Tendolkar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. Tendolkar', 'raw_affiliation_strings': ['Merck Sharp and Dohme Corp., Whitehouse Station, NJ'], 'affiliations': [{'raw_affiliation_string': 'Merck Sharp and Dohme Corp., Whitehouse Station, NJ', 'institution_ids': ['https://openalex.org/I1285764155']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5066337804', 'display_name': 'Igor D. Grachev', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I20089843', 'display_name': 'Princeton University', 'ror': 'https://ror.org/00hx57361', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I20089843']}, {'id': 'https://openalex.org/I1285764155', 'display_name': 'Merck & Co., Inc., Rahway, NJ, USA (United States)', 'ror': 'https://ror.org/02891sr49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1285764155']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'I. D. Grachev', 'raw_affiliation_strings': ['Merck Sharp and Dohme Corp., Whitehouse Station, New Jersey, at time of study', 'currently with GE Healthcare, Princeton, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'currently with GE Healthcare, Princeton, NJ, USA', 'institution_ids': ['https://openalex.org/I20089843']}, {'raw_affiliation_string': 'Merck Sharp and Dohme Corp., Whitehouse Station, New Jersey, at time of study', 'institution_ids': ['https://openalex.org/I1285764155']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2500, 'currency': 'USD', 'value_usd': 2500, 'provenance': 'doaj'}, 'apc_paid': {'value': 2500, 'currency': 'USD', 'value_usd': 2500, 'provenance': 'doaj'}, 'fwci': 2.317, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 22, 'citation_normalized_percentile': {'value': 0.806165, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '37', 'issue': '5', 'first_page': '578', 'last_page': '587'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10919', 'display_name': 'Neurological disorders and treatments', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12569', 'display_name': 'Restless Legs Syndrome Research', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.86179614}], 'concepts': [{'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.86179614}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.8168521}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.58551365}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5224466}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.420005}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.35863864}], 'mesh': [{'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001794', 'descriptor_name': 'Blood Pressure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001794', 'descriptor_name': 'Blood Pressure', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005215', 'descriptor_name': 'Fasting', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2710.2012.01349.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S156693432', 'display_name': 'Journal of Clinical Pharmacy and Therapeutics', 'issn_l': '0269-4727', 'issn': ['0269-4727', '1365-2710'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22676397', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2710.2012.01349.x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S156693432', 'display_name': 'Journal of Clinical Pharmacy and Therapeutics', 'issn_l': '0269-4727', 'issn': ['0269-4727', '1365-2710'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 23, 'referenced_works': ['https://openalex.org/W1967619230', 'https://openalex.org/W1971954940', 'https://openalex.org/W1986174590', 'https://openalex.org/W1986835295', 'https://openalex.org/W2007390314', 'https://openalex.org/W2010485061', 'https://openalex.org/W2026475932', 'https://openalex.org/W2030257205', 'https://openalex.org/W2031170958', 'https://openalex.org/W2034234729', 'https://openalex.org/W2034588648', 'https://openalex.org/W2038031154', 'https://openalex.org/W2040227196', 'https://openalex.org/W2061143550', 'https://openalex.org/W2063911036', 'https://openalex.org/W2077560786', 'https://openalex.org/W2079583442', 'https://openalex.org/W2101848275', 'https://openalex.org/W2131371182', 'https://openalex.org/W2134886133', 'https://openalex.org/W2136254234', 'https://openalex.org/W2178451042', 'https://openalex.org/W4236396139'], 'related_works': ['https://openalex.org/W4364376666', 'https://openalex.org/W4311628015', 'https://openalex.org/W3191427281', 'https://openalex.org/W3043458966', 'https://openalex.org/W2960553615', 'https://openalex.org/W2349164817', 'https://openalex.org/W2162491061', 'https://openalex.org/W2141289501', 'https://openalex.org/W2087016115', 'https://openalex.org/W1969203961'], 'abstract_inverted_index': {'What': [0, 230], 'is': [1, 8, 231], 'known': [2], 'and': [3, 34, 40, 69, 104, 111, 126, 138, 141, 146, 150, 183, 233], 'Objective:': [4], 'Preladenant': [5, 175, 235], '(SCH420814,': [6], 'MK-3814)': [7], 'a': [9, 159, 211], 'highly': [10], 'selective': [11], 'orally': [12], 'bioavailable': [13], 'non-methylxanthine': [14], 'adenosine': [15], '2A': [16], '(A2A)': [17], 'receptor': [18], 'antagonist': [19], 'under': [20, 172], 'investigation': [21], 'for': [22, 25, 43], 'the': [23, 31, 44, 70, 89, 115, 242], 'treatment': [24], "Parkinson's": [26], 'disease.': [27], 'This': [28], 'study': [29, 123], 'evaluated': [30], 'safety,': [32], 'tolerability': [33], 'pharmacokinetics': [35], 'of': [36, 93, 135], 'preladenant': [37, 62, 75, 137, 167, 215], 'at': [38, 112, 127, 200], 'single': [39, 60], 'multiple': [41, 73], 'doses': [42, 63, 76], 'first': [45], 'time': [46, 129], 'in': [47, 158, 180, 189, 206], 'humans.': [48], 'Methods:': [49], 'These': [50], 'were': [51, 108, 119, 143, 155, 191, 220], 'two': [52], 'randomized,': [53], 'double-blind,': [54], 'placebo-controlled,': [55], 'ascending-dose': [56], 'studies,': [57], 'one': [58], 'evaluating': [59, 72], 'rising': [61, 74], '(5–200': [64], 'mg)': [65], 'compared': [66, 84], 'with': [67, 85, 227], 'placebo': [68, 170], 'other': [71], '(10–200': [77], 'mg': [78], 'once': [79], 'daily': [80], 'over': [81], '10': [82], 'days)': [83], 'placebo.': [86], 'Safety': [87, 96], 'was': [88, 198, 236], 'primary': [90], 'end': [91], 'point': [92], 'both': [94], 'studies.': [95, 116], 'evaluations,': [97], 'physical': [98], 'examinations,': [99], 'electrocardiograms,': [100], 'vital': [101], 'signs': [102], 'determinations': [103], 'routine': [105], 'laboratory': [106], 'tests': [107], 'performed': [109], 'before': [110, 122], 'intervals': [113], 'throughout': [114], 'Blood': [117], 'samples': [118], 'collected': [120], 'immediately': [121], 'drug': [124], 'administration': [125], 'various': [128], 'points': [130], 'after': [131, 214], 'dosing.': [132], 'Pharmacokinetic': [133], 'assessments': [134], 'plasma': [136, 178], 'metabolites': [139], 'SCH434748': [140], 'SCH446637': [142], 'performed.': [144], 'Results': [145], 'Discussion:': [147], 'One': [148], 'hundred': [149], 'eight': [151], 'healthy': [152], 'adult': [153], 'men': [154], 'randomly': [156], 'assigned': [157], '3': [160], ':': [161], '1': [162], 'ratio': [163], 'to': [164, 194, 241], 'receive': [165], 'oral': [166], 'or': [168], 'matching': [169], 'capsules': [171], 'fasting': [173], 'conditions.': [174], 'reached': [176], 'peak': [177], 'concentrations': [179], '∼1': [181], 'h': [182], 'then': [184], 'declined': [185], 'rapidly.': [186], 'Dose-related': [187], 'increases': [188, 205], 'exposure': [190], 'observed': [192], 'up': [193, 240], '100': [195], 'mg/day;': [196], 'accumulation': [197], 'negligible': [199], 'all': [201], 'doses.': [202], 'Transient': [203], 'mild': [204], 'blood': [207, 217], 'pressure': [208, 218], 'occurred': [209], 'within': [210], 'few': [212], 'hours': [213], 'administration;': [216], 'changes': [219], 'neither': [221], 'cumulative': [222], 'nor': [223, 225], 'dose-related': [224], 'associated': [226], 'clinical': [228], 'sequelae.': [229], 'new': [232], 'Conclusion:': [234], 'generally': [237], 'well': [238], 'tolerated': [239], 'maximum': [243], 'dose': [244], 'tested': [245], '(200': [246], 'mg/day).': [247]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1830687917', 'counts_by_year': [{'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 5}, {'year': 2014, 'cited_by_count': 4}, {'year': 2013, 'cited_by_count': 2}], 'updated_date': '2024-12-14T03:54:17.397149', 'created_date': '2016-06-24'}